secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2026-01-05T23:59:59+00:00
Accession:  0001628280-26-000235
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast CBOO Tyree departs Dec 31; COO Johnson promoted to President; CEO Chard to non-exec Chairman June 1, 2026
--------------------------------------------------------------------------------

- Anthony Tyree (CBOO) departs Dec 31, 2025; receives $706,984 severance (salary + target bonus).
- Nicholas Johnson promoted from Chief Field Operations Officer to President, effective Jan 5, 2026.
- CEO Daniel Chard to transition to non-executive Chairman effective June 1, 2026; salary cut from $1M to $800K.
- Chard's target bonus reduced from 115% to 100% and LTI from $4.6M to $2.4M until transition.
- CFO James Maloney assumes leadership of supply chain function.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828026000235/0001628280-26-000235-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828026000235/med-20251230.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-000235

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer